AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...
Consumer Reports has tested the real-world ranges of some of the most popular electric cars, trucks, and SUVs on the market. Despite impressive claims, we found that many electric vehicles don’t meet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results